Peripheral RAGE (Receptor for Advanced Glycation Endproducts)-ligands in normal pregnancy and preeclampsia: Novel markers of inflammatory response

Journal of Reproductive Immunology

Volumn 93, Issue 2, 2012, Pages 69-74

  Naruse, Katsuhiko ^a   Sado, Toshiyuki ^a   Noguchi, Taketoshi ^a   Tsunemi, Taihei ^a   Yoshida, Shozo ^a   Akasaka, Juria ^a   Koike, Natsuki ^a   Oi, Hidekazu ^a   Kobayashi, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

AGEs; HMGB1; Preeclampsia; Pregnancy; RAGE; S100A12

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN; CARBOXYMETHYL LYSINE; HIGH MOBILITY GROUP B1 PROTEIN; LYSINE DERIVATIVE; S100A12 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HMGB1 PROTEIN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIGANDS; LYSINE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTERS; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS;

EID: 84858158351     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.12.003     Document Type: Article

References (28)

1. Alexiou P., Chatzopoulou M., Pegklidou K., Demopoulos V.J. RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr. Med. Chem. 2010, 17:2232-2252.
2. Buhimschi C.S., Baumbusch M.A., Dulay A.T., Oliver E.A., Lee S., Zhao G., et al. Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury. Am. J. Pathol. 2009, 175:958-975.
3. Buhimschi I.A., Zhao G., Pettker C.M., Bahtiyar M.O., Magloire L.K., Thung S., et al. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am. J. Obstet. Gynecol. 2007, 196:e1-e13.
4. Chekir C., Nakatsuka M., Noguchi S., Konishi H., Kamada Y., Sasaki A., et al. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress. Placenta 2006, 27:225-233.
5. Cooke C.L., Brockelsby J.C., Baker P.N., Davidge S.T. The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. Hypertens. Pregnancy 2003, 22:173-184.
6. Davison J.M., Homuth V., Jeyabalan A., Conrad K.P., Karumanchi S.A., Quaggin S., et al. New aspects in the pathophysiology of preeclampsia. J. Am. Soc. Nephrol. 2004, 15:2440-2448.
7. Foell D., Wittkowski H., Vogl T., Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 2007, 81:28-37.
8. Germanová A., Koucký M., Hájek Z., Parízek A., Zima T., Kalousová M. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy. Clin. Biochem. 2010, 43:442-446.
9. Heizmann C.W., Fritz G., Schäfer B.W. S100 proteins: structure, functions and pathology. Front. Biosci. 2002, 7:d1356-d1368.
10. Holmlund U., Wähämaa H., Bachmayer N., Bremme K., Sverremark-Ekström E., Palmblad K. The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta. Immunology 2007, 122:430-437.
11. Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Du Yan S., et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 1999, 274:31740-31749.
12. Kwon J.H., Kim Y.H., Kwon J.Y., Park Y.W. Clinical significance of serum sRAGE and esRAGE in women with normal pregnancy and preeclampsia. J. Perinat. Med. 2011, 39:507-513.
13. Lin L., Park S., Lakatta E.G. RAGE signaling in inflammation and arterial aging. Front. Biosci. 2009, 14:1403-1413.
14. Mazouni C., Capo C., Ledu R., Honstettre A., Agostini A., Capelle M., et al. Preeclampsia: impaired inflammatory response mediated by Toll-like receptors. J. Reprod. Immunol. 2008, 78:80-83.
15. Noguchi T., Sado T., Naruse K., Shigetomi H., Onogi A., Haruta S., et al. Evidence for activation of Toll-like receptor and receptor for advanced glycation end products in preterm birth. Mediators Inflamm. 2010, 2010:490406.
16. Reddy S., Bichler J., Wells-Knecht K.J., Thorpe S.R., Baynes J.W. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 1995, 34:10872-10878.
17. Redman C.W., Sargent I.L. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J. Reprod. Immunol. 2007, 76:61-67.
18. Redman C.W., Sargent I.L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 2010, 63:534-543.
19. Sado T., Naruse K., Noguchi T., Haruta S., Yoshida S., Tanase Y., et al. Inflammatory pattern recognition receptors and their ligands: factors contributing to the pathogenesis of preeclampsia. Inflamm. Res. 2011, 60:509-520.
20. Saito S., Shiozaki A., Nakashima A., Sakai M., Sasaki Y. The role of the immune system in preeclampsia. Mol. Aspects Med. 2007, 28:192-209.
21. Sargent I., Redman C. Does size really matter? - Placental debris, danger molecules and pre-eclampsia. Placenta 2011, 32:A12.
22. Schleicher E.D., Wagner E., Nerlich A.G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 1997, 99:457-468.
23. Stern D., Yan S.D., Yan S.F., Schmidt A.M. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv. Drug Deliv. Rev. 2002, 54:1615-1625.
24. Tskitishvili E., Sharentuya N., Temma-Asano K., Mimura K., Kinugasa-Taniguchi Y., Kanagawa T., et al. Oxidative stress-induced S100B protein from placenta and amnion affects soluble Endoglin release from endothelial cells. Mol. Hum. Reprod. 2010, 16:188-199.
25. Tsukahara H., Ohta N., Sato S., Hiraoka M., Shukunami K., Uchiyama M., et al. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood. Free Radic. Res. 2004, 38:691-695.
26. Wang B., Koga K., Osuga Y., Hirata T., Saito A., Yoshino O., et al. High mobility group box 1 (HMGB1) levels in the placenta and in serum in preeclampsia. Am. J. Reprod. Immunol. 2011, 66:143-148.
27. Yan S.F., Ramasamy R., Schmidt A.M. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J. Mol. Med. (Berl). 2009, 87:235-247.
28. Zhang S., Zhong J., Yang P., Gong F., Wang C.Y. HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int. J. Clin. Exp. Pathol. 2009, 8:24-38.